Insights
Top 5 Takeaways from the 2020 Compliance Congress
"You can corrupt a patient too."
– Assistant U.S. Attorney, Chief of Affirmative Civil Enforcement Unit – U.S. Attorney’s Office, District of Massachusetts
Synopsis
On September 21st – 24th, 2020, Informa Connect-CBI hosted its 6th Annual Compliance Congress for Specialty Products. The Congress catered to the unique Legal and Compliance challenges for specialty pharmaceutical companies focused on rare, ultra-rare and orphan diseases.
Helio Health Group identified five key takeaways from the Congress that every Compliance Officer should be considering.
Related insights
Your Data & You: Who Works for Whom?
"The expectations for companies’ use of data analytics go far beyond taking one source of data to create visualizations for a Compliance Committee or Board of Directors." - Amy Pawloski, Vice President and General Manager, ArgosSynopsis Almost every life science...
Modernize & Automate Compliance Monitoring through Digital Tools
"Allowing our customers to be self-sufficient in their compliance auditing is essential to improve efficiency and reduce internal expenses." - John Poulin, Partner and CTO, Helio ArgosSynopsis When Helio Health Group conducted an industry survey, responses indicated...